Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Euronext Paris  -  11:36 2022-10-03 am EDT
2.318 EUR   -4.53%
09/29European ADRs Move Lower in Thursday Trading
MT
09/29Biopharmaceutical Group Cellectis Hires Chief Medical Officer
MT
09/28Cellectis Promotes Mark Frattini to Chief Medical Officer
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Monday Trading

08/08/2022 | 11:08am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 0.47% 1.08 Delayed Quote.-71.33%
AMARIN CORPORATION PLC 0.46% 1.0914 Delayed Quote.-67.66%
ASCENDIS PHARMA A/S -4.65% 98.46 Delayed Quote.-23.24%
AVADEL PHARMACEUTICALS PLC -2.59% 4.87 Delayed Quote.-38.00%
BICYCLE THERAPEUTICS PLC -3.53% 22.44 Delayed Quote.-61.79%
BIONTECH SE 1.27% 136.5 Delayed Quote.-47.68%
CARNIVAL CORPORATION -2.49% 6.83 Delayed Quote.-65.06%
CELLECTIS S.A. -4.53% 2.318 Real-time Quote.-67.37%
MEREO BIOPHARMA GROUP PLC 5.57% 0.9091 Delayed Quote.-46.18%
NATUZZI S.P.A. 0.73% 6.245 Delayed Quote.-61.08%
NUCANA PLC -0.48% 1.04 Delayed Quote.-56.09%
PEARSON PLC 1.89% 883.2 Delayed Quote.41.36%
SEQUANS COMMUNICATIONS S.A. -1.26% 3.525 Delayed Quote.-24.68%
TRIVAGO N.V. 0.50% 1.1658 Delayed Quote.-46.79%
VOXELJET AG 4.63% 3.2959 Delayed Quote.-46.61%
ZEALAND PHARMA A/S -3.62% 167.5 Delayed Quote.19.78%
All news about CELLECTIS S.A.
09/29European ADRs Move Lower in Thursday Trading
MT
09/29Biopharmaceutical Group Cellectis Hires Chief Medical Officer
MT
09/28Cellectis Promotes Mark Frattini to Chief Medical Officer
MT
09/28Cellectis Appoints Mark Frattini, M.D., Ph.D. as Chief Medical Officer
GL
09/28Cellectis Appoints Mark Frattini as Chief Medical Officer
CI
09/28CELLECTIS S.A. : Changes in management and corporate officers
CO
09/27Cellectis S A : Document AMF CP. 2022E863159
PU
09/23European ADRs Fall in Friday Trading
MT
09/23Allogene Stocks Fall as Servier Abandons Anti-CD19 Partnership
AQ
09/22Cellectis S.A. and Les Laboratoires Servier Sas and Institut De Recherches Internationa..
CI
More news
Analyst Recommendations on CELLECTIS S.A.
More recommendations
Financials
Sales 2022 39,1 M 38,3 M 38,3 M
Net income 2022 -99,7 M -97,7 M -97,7 M
Net Debt 2022 93,3 M 91,5 M 91,5 M
P/E ratio 2022 -0,65x
Yield 2022 -
Capitalization 111 M 109 M 108 M
EV / Sales 2022 5,21x
EV / Sales 2023 6,71x
Nbr of Employees 297
Free-Float 99,9%
Chart CELLECTIS S.A.
Duration : Period :
Cellectis S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CELLECTIS S.A.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 2,43
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
André Choulika Chief Executive Officer & Director
Bing C. Wang Chief Financial Officer
Jean-Pierre Garnier Non-Executive Chairman
Philippe Duchateau Chief Scientific Officer
Mark Frattini Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
CELLECTIS S.A.-67.37%108
MODERNA, INC.-53.44%46 259
LONZA GROUP AG-36.15%36 760
IQVIA HOLDINGS INC.-35.80%33 784
SEAGEN INC.-11.49%25 236
ALNYLAM PHARMACEUTICALS, INC.18.03%24 025